Results 71 to 80 of about 781,057 (345)

A systematic proteomic profiling and pathway analysis of protein biomarkers in diabetic retinopathy with subsequent validation of the IL-6 upstream regulator [PDF]

open access: bronze, 2023
Zulvikar Syambani Ulhaq   +5 more
openalex   +1 more source

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation

open access: yesAdvanced Science, EarlyView.
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang   +7 more
wiley   +1 more source

Prediction and analysis of risk factors for diabetic retinopathy based on machine learning and interpretable models

open access: yesHeliyon
Objective: Diabetic retinopathy is one of the major complications of diabetes. In this study, a diabetic retinopathy risk prediction model integrating machine learning models and SHAP was established to increase the accuracy of risk prediction for ...
Xu Wang   +4 more
doaj   +1 more source

Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study

open access: yesThe Lancet: Digital Health, 2019
Summary: Background: Radical measures are required to identify and reduce blindness due to diabetes to achieve the Sustainable Development Goals by 2030.
Valentina Bellemo, MSc   +19 more
doaj   +1 more source

A Deep Learning Ensemble Approach for Diabetic Retinopathy Detection

open access: yesIEEE Access, 2019
Diabetic Retinopathy (DR) is an ophthalmic disease that damages retinal blood vessels. DR causes impaired vision and may even lead to blindness if it is not diagnosed in early stages.
Sehrish Qummar   +7 more
semanticscholar   +1 more source

Correlation of Volume of Macular Edema with Retinal Tomography Features in Diabetic Retinopathy Eyes [PDF]

open access: gold, 2021
Santosh Gopi Krishna Gadde   +6 more
openalex   +1 more source

Nanozymes Integrated Biochips Toward Smart Detection System

open access: yesAdvanced Science, EarlyView.
This review systematically outlines the integration of nanozymes, biochips, and artificial intelligence (AI) for intelligent biosensing. It details how their convergence enhances signal amplification, enables portable detection, and improves data interpretation.
Dongyu Chen   +10 more
wiley   +1 more source

Usefulness of corneal esthesiometry for screening diabetic retinopathy

open access: yesRevista de Saúde Pública, 2003
OBJECTIVE: To assess the usefulness of corneal esthesiometry for screening diabetic retinopathy. METHODS: A cross-sectional study was carried out comprising 575 patients attending a diabetic retinopathy-screening program in the city of São Paulo. Corneal
Alvarenga Lênio Souza   +6 more
doaj   +3 more sources

Microglia and Inflammatory Responses in Diabetic Retinopathy

open access: yesFrontiers in Immunology, 2020
Diabetic retinopathy is a vision-threatening disease affecting neurons and microvasculature of the retina. The development of this disease is associated with the action of inflammatory factors that are connected to the activation of microglial cells, the
Urbanus Muthai Kinuthia   +2 more
semanticscholar   +1 more source

All Nanozyme‐Based Cascade Reactions for Biomedical Applications: from Self‐Cascading Nanozyme to Immobilized Cascade Nanozyme

open access: yesAdvanced Science, EarlyView.
This review introduces the development and classification of all‐nanozyme cascade reaction systems, highlighting mechanistic insights and research methods for understanding catalytic features and design principles. It provides detailed classifications, surveys recent applications in biosensing and therapy, and discusses the challenges that all‐nanozyme
Caixia Zhu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy